GlassScriptPhysician profile
Anna S Franklin
NPI 1679754691
$121.63
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.08 · 2021: $12.17 · 2022: $43.38.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Canon Medical Systems USA, INC. | $43.38 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.42 | 2019 | |
| Abbvie INC. | $18.21 | 2019 | |
| Eisai INC. | $16.38 | 2019 | |
| Becton, Dickinson and Company | $12.17 | 2021 | |
| Boston Scientific Corporation | $11.07 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.